SCHEMBL6444267

SCHEMBL6444267

CN(C)CCOc1cccc2cc(C(=O)Nc3ccccc3N)oc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.47
NPC1 O15118 5/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HDAC1 Q13547 5/20 0.47
HDAC2 Q92769 2/20 0.45
RXFP1 Q9HBX9 1/20 0.44
ALDH1A1 P00352 3/20 0.43
GLA P06280 1/20 0.43
TP53 P04637 1/20 0.42
BMP1 P13497 1/20 0.42
HTR1B P28222 1/20 0.42
KMT2A Q03164 2/20 0.41
HDAC3 O15379 1/20 0.41
KDR P35968 1/20 0.41
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664187 0.87 HDAC1 (0.52) SMN1; SMN2HDAC1HDAC2HDAC3HPGD
SCHEMBL5564847 0.85 RXFP1 (0.44) RAB9ANPC1SMN1; SMN2L3MBTL1RXFP1
SCHEMBL6444273 0.84 HTR1B (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1HTR1B
SCHEMBL5563510 0.83 RAB9A (0.48) RAB9ANPC1SMN1; SMN2L3MBTL1HDAC1
SCHEMBL6280292 0.83 NPC1 (0.65) RAB9ANPC1SMN1; SMN2L3MBTL1HDAC1
SCHEMBL5564958 0.80 RXFP1 (0.45) RAB9ANPC1SMN1; SMN2L3MBTL1HDAC1
SCHEMBL3664185 0.80 HDAC1 (0.49) HDAC1HDAC2HDAC3KDR
SCHEMBL5559604 0.79 LMNA (0.49) RAB9ANPC1SMN1; SMN2ALDH1A1HTR1B
Anthranilamide SCHEMBL6444259 0.79 CYP1A2 (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1HTR1B
SCHEMBL3661175 0.76 HDAC2 (0.52) SMN1; SMN2HDAC1HDAC2HDAC3HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594857-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2005-11-16 EP claimed
WO-2004069133-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO claimed